BioSpace News Archive

Today Amgen Canada announced that EVENITY® (romosozumab) is now available in Canada for the treatment of osteoporosis in postmenopausal women at high risk for fracture, defined as a history of osteoporotic fracture, or multiple risk factors for fracture.

SaVida Health, a leader in outpatient medication-assisted treatment for opioid and alcohol addiction, is opening a new treatment center in Morrisville, VT on October 21st

Neurotech Reports, the publisher of the Neurotech Business Report newsletter, announced that 15 promising neurotechnology startups and early-stage firms will present at the 2019 Neurotech Leaders Forum in San Francisco, November 4-5.

Klox Technologies Inc. a regenerative medicine company focused on the development and commercialization of its proprietary fluorescent light energy biomodulation System (`FB System’) in dermatology, wound care, and animal health, today announced it has appointed two new members to its board of directors.

Expesicor announced that the National Institute of Neurological Disorders and Stroke, part of the National Institutes of Health, has awarded the company $343,042 over one year for the first phase of a Small Business Innovation Research grant award.

Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, today announced its plans to explore strategic alternatives to maximize shareholder value.

ValGenesis, Inc. announced that a global pharmaceutical manufacturing company has chosen ValGenesis’s 100% paperless VLMS to digitize and standardize its validation lifecycle process across the organization.

Immunicom, Inc., a medical technology company that has been awarded FDA Breakthrough Device Designation for its non-pharmaceutical solution for treating stage IV metastatic cancer, led multiple sessions at the annual C3 US-Arab Healthcare & Business Summit held in New York on September 23rd.

Phoenix Children’s prestigious qualification makes the health center Arizona’s only “CARF"-accredited inpatient pediatric rehabilitation program [08-October-2019] PHOENIX , Oct. 8, 2019 /PRNewswire/ -- Phoenix Children’s Hospital has received a three-year accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF). CARF Internation

NeuroSigma, Inc. announced a partnership with Quick Care Pharmacy, a California-based specialty pharmacy, for sales and distribution of its Monarch eTNS System® for the treatment of pediatric ADHD in the United States.